In a move that reflects its evolution from a biomaterial science company to a drug development company, Biopolymer Engineering, Inc., Minneapolis, MN, has changed its name to Biothera, the immune health company. Biothera’s patented technologies enable the immune system to more effectively combat a wide range of diseases. The company is currently developing several immunotherapy drugs that work synergistically with monoclonal antibodies and vaccines to treat cancer. A secondary focus is the treatment of certain widespread infectious diseases, including tuberculosis. Biothera also has a rapidly growing Healthcare group that develops, manufactures and markets food-grade, immune-enhancing ingredients for the medical foods, nutritional supplements, functional foods, cosmetics and animal feed and nutrition markets.